The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro

Intracellular transport via microtubule-based dynein and kinesin family motors plays a key role in viral reproduction and transmission. We show here that Kinesin Family Member 4 (KIF4) plays an important role in HBV/HDV infection. We intended to explore host factors impacting the HBV life cycle that...

Full description

Saved in:
Bibliographic Details
Published in:PLoS pathogens Vol. 18; no. 3; p. e1009983
Main Authors: Gad, Sameh A, Sugiyama, Masaya, Tsuge, Masataka, Wakae, Kosho, Fukano, Kento, Oshima, Mizuki, Sureau, Camille, Watanabe, Noriyuki, Kato, Takanobu, Murayama, Asako, Li, Yingfang, Shoji, Ikuo, Shimotohno, Kunitada, Chayama, Kazuaki, Muramatsu, Masamichi, Wakita, Takaji, Nozaki, Tomoyoshi, Aly, Hussein H
Format: Journal Article
Language:English
Published: United States Public Library of Science 01-03-2022
Public Library of Science (PLoS)
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Intracellular transport via microtubule-based dynein and kinesin family motors plays a key role in viral reproduction and transmission. We show here that Kinesin Family Member 4 (KIF4) plays an important role in HBV/HDV infection. We intended to explore host factors impacting the HBV life cycle that can be therapeutically addressed using siRNA library transfection and HBV/NLuc (HBV/NL) reporter virus infection in HepG2-hNTCP cells. KIF4 silencing resulted in a 3-fold reduction in luciferase activity following HBV/NL infection. KIF4 knockdown suppressed both HBV and HDV infection. Transient KIF4 depletion reduced surface and raised intracellular NTCP (HBV/HDV entry receptor) levels, according to both cellular fractionation and immunofluorescence analysis (IF). Overexpression of wild-type KIF4 but not ATPase-null KIF4 mutant regained the surface localization of NTCP and significantly restored HBV permissiveness in these cells. IF revealed KIF4 and NTCP colocalization across microtubule filaments, and a co-immunoprecipitation study revealed that KIF4 interacts with NTCP. KIF4 expression is regulated by FOXM1. Interestingly, we discovered that RXR agonists (Bexarotene, and Alitretinoin) down-regulated KIF4 expression via FOXM1-mediated suppression, resulting in a substantial decrease in HBV-Pre-S1 protein attachment to HepG2-hNTCP cell surface and subsequent HBV infection in both HepG2-hNTCP and primary human hepatocyte (PXB) (Bexarotene, IC50 1.89 ± 0.98 μM) cultures. Overall, our findings show that human KIF4 is a critical regulator of NTCP surface transport and localization, which is required for NTCP to function as a receptor for HBV/HDV entry. Furthermore, small molecules that suppress or alleviate KIF4 expression would be potential antiviral candidates targeting HBV and HDV entry.
AbstractList Intracellular transport via microtubule-based dynein and kinesin family motors plays a key role in viral reproduction and transmission. We show here that Kinesin Family Member 4 (KIF4) plays an important role in HBV/HDV infection. We intended to explore host factors impacting the HBV life cycle that can be therapeutically addressed using siRNA library transfection and HBV/NLuc (HBV/NL) reporter virus infection in HepG2-hNTCP cells. KIF4 silencing resulted in a 3-fold reduction in luciferase activity following HBV/NL infection. KIF4 knockdown suppressed both HBV and HDV infection. Transient KIF4 depletion reduced surface and raised intracellular NTCP (HBV/HDV entry receptor) levels, according to both cellular fractionation and immunofluorescence analysis (IF). Overexpression of wild-type KIF4 but not ATPase-null KIF4 mutant regained the surface localization of NTCP and significantly restored HBV permissiveness in these cells. IF revealed KIF4 and NTCP colocalization across microtubule filaments, and a co-immunoprecipitation study revealed that KIF4 interacts with NTCP. KIF4 expression is regulated by FOXM1. Interestingly, we discovered that RXR agonists (Bexarotene, and Alitretinoin) down-regulated KIF4 expression via FOXM1-mediated suppression, resulting in a substantial decrease in HBV-Pre-S1 protein attachment to HepG2-hNTCP cell surface and subsequent HBV infection in both HepG2-hNTCP and primary human hepatocyte (PXB) (Bexarotene, IC50 1.89 ± 0.98 μM) cultures. Overall, our findings show that human KIF4 is a critical regulator of NTCP surface transport and localization, which is required for NTCP to function as a receptor for HBV/HDV entry. Furthermore, small molecules that suppress or alleviate KIF4 expression would be potential antiviral candidates targeting HBV and HDV entry.
Intracellular transport via microtubule-based dynein and kinesin family motors plays a key role in viral reproduction and transmission. We show here that Kinesin Family Member 4 (KIF4) plays an important role in HBV/HDV infection. We intended to explore host factors impacting the HBV life cycle that can be therapeutically addressed using siRNA library transfection and HBV/NLuc (HBV/NL) reporter virus infection in HepG2-hNTCP cells. KIF4 silencing resulted in a 3-fold reduction in luciferase activity following HBV/NL infection. KIF4 knockdown suppressed both HBV and HDV infection. Transient KIF4 depletion reduced surface and raised intracellular NTCP (HBV/HDV entry receptor) levels, according to both cellular fractionation and immunofluorescence analysis (IF). Overexpression of wild-type KIF4 but not ATPase-null KIF4 mutant regained the surface localization of NTCP and significantly restored HBV permissiveness in these cells. IF revealed KIF4 and NTCP colocalization across microtubule filaments, and a co-immunoprecipitation study revealed that KIF4 interacts with NTCP. KIF4 expression is regulated by FOXM1. Interestingly, we discovered that RXR agonists (Bexarotene, and Alitretinoin) down-regulated KIF4 expression via FOXM1-mediated suppression, resulting in a substantial decrease in HBV-Pre-S1 protein attachment to HepG2-hNTCP cell surface and subsequent HBV infection in both HepG2-hNTCP and primary human hepatocyte (PXB) (Bexarotene, IC 50 1.89 ± 0.98 μM) cultures. Overall, our findings show that human KIF4 is a critical regulator of NTCP surface transport and localization, which is required for NTCP to function as a receptor for HBV/HDV entry. Furthermore, small molecules that suppress or alleviate KIF4 expression would be potential antiviral candidates targeting HBV and HDV entry. Understanding HBV/HDV entry machinery and the mechanism by which NTCP (HBV/HDV entry receptor) surface expression is regulated is crucial to develop antiviral entry inhibitors. We found that NTCP surface transport is mainly controlled by the motor kinesin KIF4. Surprisingly, KIF4 was negatively regulated by RXR receptors through FOXM1-mediated suppression. This study not only mechanistically correlated the role of RXR receptors in regulating HBV/HDV entry but also suggested a novel approach to develop therapeutic rexinoids for preventing HBV and/or HDV infections in important clinical situations, such as in patients undergoing liver transplantation or those who are at a high risk of HBV infection and unresponsive to HBV vaccination.
Intracellular transport via microtubule-based dynein and kinesin family motors plays a key role in viral reproduction and transmission. We show here that Kinesin Family Member 4 (KIF4) plays an important role in HBV/HDV infection. We intended to explore host factors impacting the HBV life cycle that can be therapeutically addressed using siRNA library transfection and HBV/NLuc (HBV/NL) reporter virus infection in HepG2-hNTCP cells. KIF4 silencing resulted in a 3-fold reduction in luciferase activity following HBV/NL infection. KIF4 knockdown suppressed both HBV and HDV infection. Transient KIF4 depletion reduced surface and raised intracellular NTCP (HBV/HDV entry receptor) levels, according to both cellular fractionation and immunofluorescence analysis (IF). Overexpression of wild-type KIF4 but not ATPase-null KIF4 mutant regained the surface localization of NTCP and significantly restored HBV permissiveness in these cells. IF revealed KIF4 and NTCP colocalization across microtubule filaments, and a co-immunoprecipitation study revealed that KIF4 interacts with NTCP. KIF4 expression is regulated by FOXM1. Interestingly, we discovered that RXR agonists (Bexarotene, and Alitretinoin) down-regulated KIF4 expression via FOXM1-mediated suppression, resulting in a substantial decrease in HBV-Pre-S1 protein attachment to HepG2-hNTCP cell surface and subsequent HBV infection in both HepG2-hNTCP and primary human hepatocyte (PXB) (Bexarotene, IC.sub.50 1.89 ± 0.98 [mu]M) cultures. Overall, our findings show that human KIF4 is a critical regulator of NTCP surface transport and localization, which is required for NTCP to function as a receptor for HBV/HDV entry. Furthermore, small molecules that suppress or alleviate KIF4 expression would be potential antiviral candidates targeting HBV and HDV entry.
Intracellular transport via microtubule-based dynein and kinesin family motors plays a key role in viral reproduction and transmission. We show here that Kinesin Family Member 4 (KIF4) plays an important role in HBV/HDV infection. We intended to explore host factors impacting the HBV life cycle that can be therapeutically addressed using siRNA library transfection and HBV/NLuc (HBV/NL) reporter virus infection in HepG2-hNTCP cells. KIF4 silencing resulted in a 3-fold reduction in luciferase activity following HBV/NL infection. KIF4 knockdown suppressed both HBV and HDV infection. Transient KIF4 depletion reduced surface and raised intracellular NTCP (HBV/HDV entry receptor) levels, according to both cellular fractionation and immunofluorescence analysis (IF). Overexpression of wild-type KIF4 but not ATPase-null KIF4 mutant regained the surface localization of NTCP and significantly restored HBV permissiveness in these cells. IF revealed KIF4 and NTCP colocalization across microtubule filaments, and a co-immunoprecipitation study revealed that KIF4 interacts with NTCP. KIF4 expression is regulated by FOXM1. Interestingly, we discovered that RXR agonists (Bexarotene, and Alitretinoin) down-regulated KIF4 expression via FOXM1-mediated suppression, resulting in a substantial decrease in HBV-Pre-S1 protein attachment to HepG2-hNTCP cell surface and subsequent HBV infection in both HepG2-hNTCP and primary human hepatocyte (PXB) (Bexarotene, IC 50 1.89 ± 0.98 μM) cultures. Overall, our findings show that human KIF4 is a critical regulator of NTCP surface transport and localization, which is required for NTCP to function as a receptor for HBV/HDV entry. Furthermore, small molecules that suppress or alleviate KIF4 expression would be potential antiviral candidates targeting HBV and HDV entry.
Audience Academic
Author Shimotohno, Kunitada
Fukano, Kento
Shoji, Ikuo
Gad, Sameh A
Sureau, Camille
Tsuge, Masataka
Kato, Takanobu
Wakita, Takaji
Murayama, Asako
Li, Yingfang
Watanabe, Noriyuki
Sugiyama, Masaya
Muramatsu, Masamichi
Oshima, Mizuki
Chayama, Kazuaki
Nozaki, Tomoyoshi
Wakae, Kosho
Aly, Hussein H
AuthorAffiliation 6 Graduate School of Science and Technology, Tokyo University of Science, Noda, Japan
12 RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
7 Institut National de la Transfusion Sanguine, Paris, France
2 Department of Biomedical Chemistry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
9 Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan
10 Collaborative Research Laboratory of Medical Innovation, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
3 Department of Microbiology and Immunology, Faculty of Pharmacy, Minia University, Minia, Egypt
5 Natural Science Center for Basic Research and Development, Hiroshima University, Hiroshima, Japan
1 Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan
11 Research Center for Hepatology and Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
8 Center for
AuthorAffiliation_xml – name: 5 Natural Science Center for Basic Research and Development, Hiroshima University, Hiroshima, Japan
– name: 8 Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan
– name: 7 Institut National de la Transfusion Sanguine, Paris, France
– name: 11 Research Center for Hepatology and Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
– name: 4 Genome Medical Sciences Project, National Center for Global Health and Medicine, Chiba, Japan
– name: 6 Graduate School of Science and Technology, Tokyo University of Science, Noda, Japan
– name: 9 Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan
– name: The Pennsylvania State University College of Medicine, UNITED STATES
– name: 2 Department of Biomedical Chemistry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
– name: 3 Department of Microbiology and Immunology, Faculty of Pharmacy, Minia University, Minia, Egypt
– name: 1 Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan
– name: 12 RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
– name: 10 Collaborative Research Laboratory of Medical Innovation, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
Author_xml – sequence: 1
  givenname: Sameh A
  orcidid: 0000-0003-3612-2977
  surname: Gad
  fullname: Gad, Sameh A
  organization: Department of Microbiology and Immunology, Faculty of Pharmacy, Minia University, Minia, Egypt
– sequence: 2
  givenname: Masaya
  orcidid: 0000-0002-9084-7197
  surname: Sugiyama
  fullname: Sugiyama, Masaya
  organization: Genome Medical Sciences Project, National Center for Global Health and Medicine, Chiba, Japan
– sequence: 3
  givenname: Masataka
  orcidid: 0000-0001-7591-8287
  surname: Tsuge
  fullname: Tsuge, Masataka
  organization: Natural Science Center for Basic Research and Development, Hiroshima University, Hiroshima, Japan
– sequence: 4
  givenname: Kosho
  surname: Wakae
  fullname: Wakae, Kosho
  organization: Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan
– sequence: 5
  givenname: Kento
  orcidid: 0000-0002-0030-6072
  surname: Fukano
  fullname: Fukano, Kento
  organization: Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan
– sequence: 6
  givenname: Mizuki
  surname: Oshima
  fullname: Oshima, Mizuki
  organization: Graduate School of Science and Technology, Tokyo University of Science, Noda, Japan
– sequence: 7
  givenname: Camille
  surname: Sureau
  fullname: Sureau, Camille
  organization: Institut National de la Transfusion Sanguine, Paris, France
– sequence: 8
  givenname: Noriyuki
  orcidid: 0000-0001-6101-6928
  surname: Watanabe
  fullname: Watanabe, Noriyuki
  organization: Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan
– sequence: 9
  givenname: Takanobu
  orcidid: 0000-0003-1620-1360
  surname: Kato
  fullname: Kato, Takanobu
  organization: Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan
– sequence: 10
  givenname: Asako
  surname: Murayama
  fullname: Murayama, Asako
  organization: Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan
– sequence: 11
  givenname: Yingfang
  surname: Li
  fullname: Li, Yingfang
  organization: Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan
– sequence: 12
  givenname: Ikuo
  orcidid: 0000-0002-0730-4379
  surname: Shoji
  fullname: Shoji, Ikuo
  organization: Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan
– sequence: 13
  givenname: Kunitada
  surname: Shimotohno
  fullname: Shimotohno, Kunitada
  organization: Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan
– sequence: 14
  givenname: Kazuaki
  surname: Chayama
  fullname: Chayama, Kazuaki
  organization: RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
– sequence: 15
  givenname: Masamichi
  orcidid: 0000-0002-0153-3533
  surname: Muramatsu
  fullname: Muramatsu, Masamichi
  organization: Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan
– sequence: 16
  givenname: Takaji
  surname: Wakita
  fullname: Wakita, Takaji
  organization: Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan
– sequence: 17
  givenname: Tomoyoshi
  orcidid: 0000-0003-1354-5133
  surname: Nozaki
  fullname: Nozaki, Tomoyoshi
  organization: Department of Biomedical Chemistry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
– sequence: 18
  givenname: Hussein H
  orcidid: 0000-0002-2455-0694
  surname: Aly
  fullname: Aly, Hussein H
  organization: Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35312737$$D View this record in MEDLINE/PubMed
BookMark eNqVk01v1DAQhiNURD_gHyCwxAUOu7Xjj2wuSKVQuqIqaFkqbpbjTLJus_ZiOxXlF_Czcdht1UW9oBwceZ55Z-aVZz_bsc5Clj0neExoQQ4vXe-t6sarlYpjgnFZTuijbI9wTkcFLdjOvf_dbD-ES4wZoUQ8yXYppyRPgb3s93wB6MpYCMaiT9MThpZQGxUhoNN3F4en7y8Q2OhvUFx417eLdALy0PadisZZ5BoUet8oDeh8fvwFdU6rzvxaB5WtkVYWVYCi8i1EqFF1g2bfZ0i1zpoQA0plr0307mn2uFFdgGeb8yD7dvJhfnw6Ovv8cXp8dDbSQpA4yidVmcavMC9zTnheMFFPKAVSCAENF4SWoHiB67zGmkFRFDUp8qoh5YRpJQQ9yF6udVedC3JjYpC54IRwTFmeiOmaqJ26lCtvlsrfSKeM_HvhfCuVj0Z3IIGIhuZ10WjGWc7LUvFKEIGx0JyICpLW2021vkrG6sFL1W2JbkesWcjWXctJWWCeD-2-3gh496OHEOXSBA1dpyy4fuibkQkXRT70_eof9OHpNlSr0gDGNi7V1YOoPBJlyWiJGU3U-AEqfTUsjU4PsTHpfivhzVZCYiL8jK3qQ5DTr7P_YM-3WbZmtXcheGjuvCNYDntwO6Qc9kBu9iClvbjv-13S7cOnfwCPTAMJ
CitedBy_id crossref_primary_10_1080_17460794_2024_2342135
crossref_primary_10_1016_j_jpha_2024_100979
crossref_primary_10_1083_jcb_202212084
crossref_primary_10_2217_fvl_2023_0210
crossref_primary_10_1016_j_bcp_2023_115956
crossref_primary_10_1515_hsz_2022_0345
Cites_doi 10.1073/pnas.1811064116
10.1136/gutjnl-2015-309809
10.1136/gut.24.7.618
10.1073/pnas.111145398
10.1056/NEJM199312163292503
10.1111/cas.12799
10.1101/gad.282855.116
10.1073/pnas.2021475118
10.1128/JVI.02203-18
10.1128/JVI.01771-17
10.1038/s41598-017-11015-4
10.1136/bmj.m2200
10.1016/j.jhep.2012.12.008
10.1016/j.antiviral.2012.12.008
10.1016/j.jhep.2016.11.009
10.1111/liv.13427
10.1016/j.jhep.2016.02.013
10.1016/j.antiviral.2014.03.017
10.1128/JVI.73.12.10508-10513.1999
10.1242/jcs.02304
10.1074/jbc.M116.724641
10.1016/j.bbrc.2013.12.052
10.1002/hep.26982
10.1002/hep.510250521
10.1042/BCJ20170548
10.1128/JVI.01855-15
10.1016/j.mcn.2014.09.003
10.1016/j.bbrc.2008.05.065
10.1016/j.coviro.2018.04.004
10.1128/JVI.00767-21
10.1038/nrm2774
10.1083/jcb.129.3.709
10.1016/j.ejphar.2020.173346
10.3851/IMP2965
10.1074/jbc.M113.501122
10.1016/0092-8674(95)90376-3
10.1371/journal.pone.0215234
10.3389/fmicb.2018.03257
10.1016/j.antiviral.2015.06.007
10.1371/journal.ppat.1007055
10.1083/jcb.149.1.141
10.1242/jcs.064113
10.1016/j.chom.2013.10.012
10.1002/hep.27694
10.1038/ncb1217
10.1073/pnas.78.6.3906
10.1016/j.antiviral.2014.09.009
10.1016/j.gene.2018.08.005
10.1186/s13046-019-1202-3
10.1128/jvi.68.6.4063-4066.1994
10.3892/mmr.2015.3792
10.1128/jvi.63.5.1945-1950.1989
10.7150/jca.26052
10.1136/gutjnl-2016-312162
10.3389/fimmu.2021.712241
10.1002/hep.27240
10.1128/JVI.02478-06
10.3389/fcimb.2020.00074
10.1074/jbc.M114.602540
10.1083/jcb.200403036
10.1152/ajpgi.2001.280.6.G1305
10.1002/hep.24707
ContentType Journal Article
Copyright COPYRIGHT 2022 Public Library of Science
2022 Gad et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022 Gad et al 2022 Gad et al
Copyright_xml – notice: COPYRIGHT 2022 Public Library of Science
– notice: 2022 Gad et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022 Gad et al 2022 Gad et al
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
ISN
ISR
3V.
7QL
7U9
7X7
7XB
88E
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1371/journal.ppat.1009983
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Gale In Context: Canada
Gale In Context: Science
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
AUTh Library subscriptions: ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Biological Science Database
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE



CrossRef
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate KIF4 regulates NTCP-mediated HBV/HDV entry
EISSN 1553-7374
Editor Hu, Jianming
Editor_xml – sequence: 1
  givenname: Jianming
  surname: Hu
  fullname: Hu, Jianming
EndPage e1009983
ExternalDocumentID 2651150342
oai_doaj_org_article_e16f32d7fc4542599a5b616006c516be
A699439043
10_1371_journal_ppat_1009983
35312737
Genre Journal Article
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GrantInformation_xml – fundername: ;
  grantid: 19K07586
– fundername: ;
  grantid: 20fk0310109h0004
– fundername: ;
  grantid: 21fk0310109j0405
– fundername: ;
  grantid: 21fk0310103j0305
– fundername: ;
  grantid: Egyptian Japanese Education Partnership-3 (EJEP-3) PhD scholarship
– fundername: ;
  grantid: 21fk0310104j0905
GroupedDBID ---
123
29O
2WC
3V.
53G
5VS
7X7
88E
8FE
8FH
8FI
8FJ
AAFWJ
ABDBF
ABUWG
ACGFO
ACIHN
ACPRK
ADBBV
ADRAZ
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
B0M
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
BWKFM
CCPQU
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EAP
EAS
EBD
ECM
EIF
EMK
EMOBN
ESX
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
H13
HCIFZ
HMCUK
HYE
IAO
IHR
INH
INR
IPNFZ
ISN
ISR
ITC
KQ8
LK8
M1P
M48
M7P
MM.
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
PV9
QF4
QN7
RIG
RNS
RPM
RZL
SV3
TR2
TUS
UKHRP
WOQ
WOW
~8M
AAYXX
CITATION
7QL
7U9
7XB
8FK
AZQEC
C1K
DWQXO
GNUQQ
H94
K9.
PQEST
PQUKI
PRINS
7X8
5PM
-
AAPBV
ABPTK
ADACO
BBAFP
ID FETCH-LOGICAL-c661t-28b9137b05925152746d833e1766ef56139ea570d2d0c4e777d172bf1984ca663
IEDL.DBID RPM
ISSN 1553-7374
1553-7366
IngestDate Sun May 01 00:10:38 EDT 2022
Tue Oct 22 15:13:37 EDT 2024
Tue Sep 17 21:34:57 EDT 2024
Fri Aug 16 23:38:09 EDT 2024
Thu Oct 10 18:33:20 EDT 2024
Tue Nov 19 20:46:05 EST 2024
Tue Nov 12 22:08:31 EST 2024
Thu Aug 01 19:39:10 EDT 2024
Thu Aug 01 20:12:23 EDT 2024
Fri Aug 23 01:31:07 EDT 2024
Sat Sep 28 08:21:21 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c661t-28b9137b05925152746d833e1766ef56139ea570d2d0c4e777d172bf1984ca663
Notes new_version
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
The authors have declared that no competing interests exist.
ORCID 0000-0002-0730-4379
0000-0003-1620-1360
0000-0002-0153-3533
0000-0003-1354-5133
0000-0001-6101-6928
0000-0002-2455-0694
0000-0002-9084-7197
0000-0003-3612-2977
0000-0001-7591-8287
0000-0002-0030-6072
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970526/
PMID 35312737
PQID 2651150342
PQPubID 1436335
ParticipantIDs plos_journals_2651150342
doaj_primary_oai_doaj_org_article_e16f32d7fc4542599a5b616006c516be
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8970526
proquest_miscellaneous_2641856722
proquest_journals_2651150342
gale_infotracmisc_A699439043
gale_infotracacademiconefile_A699439043
gale_incontextgauss_ISR_A699439043
gale_incontextgauss_ISN_A699439043
crossref_primary_10_1371_journal_ppat_1009983
pubmed_primary_35312737
PublicationCentury 2000
PublicationDate 2022-03-01
PublicationDateYYYYMMDD 2022-03-01
PublicationDate_xml – month: 03
  year: 2022
  text: 2022-03-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PLoS pathogens
PublicationTitleAlternate PLoS Pathog
PublicationYear 2022
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References M. Nassal (ppat.1009983.ref001) 2015; 64
CL Zhu (ppat.1009983.ref015) 2015; 12
M Blanchet (ppat.1009983.ref037) 2014; 106
HN Skold (ppat.1009983.ref006) 2005; 118
S Shimura (ppat.1009983.ref065) 2017; 66
C Sureau (ppat.1009983.ref002) 2016; 64
NM Gretskaya (ppat.1009983.ref043) 2020; 883
T Tu (ppat.1009983.ref045) 2018; 30
K Osei-Sarfo (ppat.1009983.ref021) 2019; 14
S Gudima (ppat.1009983.ref059) 2007; 81
W Zhou (ppat.1009983.ref017) 2017; 37
D Samuel (ppat.1009983.ref047) 1993; 329
L Deng (ppat.1009983.ref060) 2019; 93
J Lucifora (ppat.1009983.ref039) 2013; 97
S Tsukuda (ppat.1009983.ref041) 2015; 290
AQ Sun (ppat.1009983.ref033) 2001; 280
J Laoukili (ppat.1009983.ref056) 2005; 7
H Yan (ppat.1009983.ref003) 2012; 3
FM Vaz (ppat.1009983.ref034) 2015; 61
HC Huang (ppat.1009983.ref042) 2014; 111
T Volz (ppat.1009983.ref022) 2013; 58
MK Ibrahim (ppat.1009983.ref053) 2021
H Nishitsuji (ppat.1009983.ref023) 2015; 106
J Scotto (ppat.1009983.ref050) 1983; 24
MK Ibrahim (ppat.1009983.ref016) 2021; 95
J Powers (ppat.1009983.ref008) 2004; 166
Y Sabo (ppat.1009983.ref012) 2013; 14
M Kaneko (ppat.1009983.ref036) 2015; 89
BC Williams (ppat.1009983.ref009) 1995; 129
K Watashi (ppat.1009983.ref046) 2014; 59
L Sheng (ppat.1009983.ref011) 2018; 678
CM Gaunt (ppat.1009983.ref029) 2021; 12
JD Londino (ppat.1009983.ref062) 2017; 474
Y Shi (ppat.1009983.ref004) 2020; 370
N Janakiram (ppat.1009983.ref044) 2007; 67
D Peretti (ppat.1009983.ref020) 2000; 149
K Watashi (ppat.1009983.ref064) 2013; 288
BL Shneider (ppat.1009983.ref031) 1997; 25
HH Aly (ppat.1009983.ref061) 2016; 291
D Slijepcevic (ppat.1009983.ref035) 2015; 62
M Iwamoto (ppat.1009983.ref051) 2014; 443
I Vernos (ppat.1009983.ref010) 1995; 81
G Hu (ppat.1009983.ref014) 2019; 38
M Takahashi (ppat.1009983.ref054) 2016; 30
TG Heintz (ppat.1009983.ref025) 2014; 63
N Hirokawa (ppat.1009983.ref024) 2009; 10
M Song (ppat.1009983.ref028) 2018; 92
M Iwamoto (ppat.1009983.ref052) 2017; 7
G Wu (ppat.1009983.ref018) 2008; 372
A Schulze (ppat.1009983.ref032) 2012; 55
XJ Wang (ppat.1009983.ref040) 2015; 120
Q Hu (ppat.1009983.ref030) 2020; 10
L Yang (ppat.1009983.ref048) 2018; 9
S Mukhopadhyay (ppat.1009983.ref063) 2021; 118
SA Endow (ppat.1009983.ref007) 2010; 123
J Zhou (ppat.1009983.ref013) 2018; 14
K Fukano (ppat.1009983.ref055) 2018; 9
C Sureau (ppat.1009983.ref058) 1994; 68
H Miki (ppat.1009983.ref005) 2001; 98
MY Kuo (ppat.1009983.ref057) 1989; 63
C Ko (ppat.1009983.ref038) 2015; 20
C Brechot (ppat.1009983.ref049) 1981; 78
L Allweiss (ppat.1009983.ref019) 2018; 67
M Iwamoto (ppat.1009983.ref027) 2019; 116
Y Tang (ppat.1009983.ref026) 1999; 73
References_xml – volume: 116
  start-page: 8487
  issue: 17
  year: 2019
  ident: ppat.1009983.ref027
  article-title: Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1811064116
  contributor:
    fullname: M Iwamoto
– volume: 64
  start-page: 1972
  issue: 12
  year: 2015
  ident: ppat.1009983.ref001
  article-title: HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B
  publication-title: Gut
  doi: 10.1136/gutjnl-2015-309809
  contributor:
    fullname: M. Nassal
– volume: 3
  year: 2012
  ident: ppat.1009983.ref003
  article-title: Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
  publication-title: Elife
  contributor:
    fullname: H Yan
– volume: 24
  start-page: 618
  issue: 7
  year: 1983
  ident: ppat.1009983.ref050
  article-title: Hepatitis B virus DNA in children’s liver diseases: detection by blot hybridisation in liver and serum
  publication-title: Gut
  doi: 10.1136/gut.24.7.618
  contributor:
    fullname: J Scotto
– volume: 98
  start-page: 7004
  issue: 13
  year: 2001
  ident: ppat.1009983.ref005
  article-title: All kinesin superfamily protein, KIF, genes in mouse and human
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.111145398
  contributor:
    fullname: H Miki
– volume: 329
  start-page: 1842
  issue: 25
  year: 1993
  ident: ppat.1009983.ref047
  article-title: Liver transplantation in European patients with the hepatitis B surface antigen
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199312163292503
  contributor:
    fullname: D Samuel
– volume: 106
  start-page: 1616
  issue: 11
  year: 2015
  ident: ppat.1009983.ref023
  article-title: Novel reporter system to monitor early stages of the hepatitis B virus life cycle
  publication-title: Cancer Sci
  doi: 10.1111/cas.12799
  contributor:
    fullname: H Nishitsuji
– volume: 30
  start-page: 1931
  issue: 17
  year: 2016
  ident: ppat.1009983.ref054
  article-title: Condensin I-mediated mitotic chromosome assembly requires association with chromokinesin KIF4A
  publication-title: Genes Dev
  doi: 10.1101/gad.282855.116
  contributor:
    fullname: M Takahashi
– volume: 118
  issue: 6
  year: 2021
  ident: ppat.1009983.ref063
  article-title: Autophagy is required for proper cysteine homeostasis in pancreatic cancer through regulation of SLC7A11
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.2021475118
  contributor:
    fullname: S Mukhopadhyay
– volume: 93
  issue: 6
  year: 2019
  ident: ppat.1009983.ref060
  article-title: Peroxiredoxin 1, a Novel HBx-Interacting Protein, Interacts with Exosome Component 5 and Negatively Regulates Hepatitis B Virus (HBV) Propagation through Degradation of HBV RNA.
  publication-title: J Virol
  doi: 10.1128/JVI.02203-18
  contributor:
    fullname: L Deng
– volume: 92
  issue: 8
  year: 2018
  ident: ppat.1009983.ref028
  article-title: Silencing Retinoid X Receptor Alpha Expression Enhances Early-Stage Hepatitis B Virus Infection In Cell Cultures
  publication-title: J Virol
  doi: 10.1128/JVI.01771-17
  contributor:
    fullname: M Song
– volume: 7
  start-page: 10620
  issue: 1
  year: 2017
  ident: ppat.1009983.ref052
  article-title: Functional association of cellular microtubules with viral capsid assembly supports efficient hepatitis B virus replication.
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-11015-4
  contributor:
    fullname: M Iwamoto
– volume: 370
  start-page: m2200
  year: 2020
  ident: ppat.1009983.ref004
  article-title: Hepatitis B virus persistence and reactivation
  publication-title: BMJ
  doi: 10.1136/bmj.m2200
  contributor:
    fullname: Y Shi
– volume: 58
  start-page: 861
  issue: 5
  year: 2013
  ident: ppat.1009983.ref022
  article-title: The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2012.12.008
  contributor:
    fullname: T Volz
– volume: 97
  start-page: 195
  issue: 2
  year: 2013
  ident: ppat.1009983.ref039
  article-title: Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytes
  publication-title: Antiviral Res
  doi: 10.1016/j.antiviral.2012.12.008
  contributor:
    fullname: J Lucifora
– volume: 66
  start-page: 685
  issue: 4
  year: 2017
  ident: ppat.1009983.ref065
  article-title: Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2016.11.009
  contributor:
    fullname: S Shimura
– volume: 67
  start-page: 1657
  issue: 9 Supplement
  year: 2007
  ident: ppat.1009983.ref044
  article-title: Combined effects of raloxifene (SERM) and bexarotene (Rexinoid) on growth suppression of colon cancer cells.
  publication-title: Cancer Research
  contributor:
    fullname: N Janakiram
– volume: 37
  start-page: 1632
  issue: 11
  year: 2017
  ident: ppat.1009983.ref017
  article-title: Predictive model for inflammation grades of chronic hepatitis B: Large-scale analysis of clinical parameters and gene expressions
  publication-title: Liver Int
  doi: 10.1111/liv.13427
  contributor:
    fullname: W Zhou
– volume: 64
  start-page: S102
  issue: 1 Suppl
  year: 2016
  ident: ppat.1009983.ref002
  article-title: The hepatitis delta virus: Replication and pathogenesis
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2016.02.013
  contributor:
    fullname: C Sureau
– volume: 106
  start-page: 111
  year: 2014
  ident: ppat.1009983.ref037
  article-title: Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle
  publication-title: Antiviral Res
  doi: 10.1016/j.antiviral.2014.03.017
  contributor:
    fullname: M Blanchet
– volume: 73
  start-page: 10508
  issue: 12
  year: 1999
  ident: ppat.1009983.ref026
  article-title: Cellular motor protein KIF-4 associates with retroviral Gag
  publication-title: J Virol
  doi: 10.1128/JVI.73.12.10508-10513.1999
  contributor:
    fullname: Y Tang
– volume: 118
  start-page: 1745
  issue: Pt 8
  year: 2005
  ident: ppat.1009983.ref006
  article-title: Assembly pathway of the anastral Drosophila oocyte meiosis I spindle
  publication-title: J Cell Sci
  doi: 10.1242/jcs.02304
  contributor:
    fullname: HN Skold
– volume: 291
  start-page: 15958
  issue: 31
  year: 2016
  ident: ppat.1009983.ref061
  article-title: RNA Exosome Complex Regulates Stability of the Hepatitis B Virus X-mRNA Transcript in a Non-stop-mediated (NSD) RNA Quality Control Mechanism.
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M116.724641
  contributor:
    fullname: HH Aly
– volume: 443
  start-page: 808
  issue: 3
  year: 2014
  ident: ppat.1009983.ref051
  article-title: Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2013.12.052
  contributor:
    fullname: M Iwamoto
– volume: 59
  start-page: 1726
  issue: 5
  year: 2014
  ident: ppat.1009983.ref046
  article-title: Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP).
  publication-title: Hepatology
  doi: 10.1002/hep.26982
  contributor:
    fullname: K Watashi
– volume: 25
  start-page: 1176
  issue: 5
  year: 1997
  ident: ppat.1009983.ref031
  article-title: Hepatic basolateral sodium-dependent-bile acid transporter expression in two unusual cases of hypercholanemia and in extrahepatic biliary atresia
  publication-title: Hepatology
  doi: 10.1002/hep.510250521
  contributor:
    fullname: BL Shneider
– volume: 474
  start-page: 3543
  issue: 20
  year: 2017
  ident: ppat.1009983.ref062
  article-title: Post-translational modification of the interferon-gamma receptor alters its stability and signaling
  publication-title: Biochem J
  doi: 10.1042/BCJ20170548
  contributor:
    fullname: JD Londino
– volume: 89
  start-page: 11945
  issue: 23
  year: 2015
  ident: ppat.1009983.ref036
  article-title: A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide
  publication-title: J Virol
  doi: 10.1128/JVI.01855-15
  contributor:
    fullname: M Kaneko
– year: 2021
  ident: ppat.1009983.ref053
  article-title: MafF is an antiviral host factor that suppresses transcription from Hepatitis B Virus core promoter
  publication-title: J Virol
  contributor:
    fullname: MK Ibrahim
– volume: 63
  start-page: 60
  year: 2014
  ident: ppat.1009983.ref025
  article-title: Kinesin KIF4A transports integrin beta1 in developing axons of cortical neurons
  publication-title: Mol Cell Neurosci
  doi: 10.1016/j.mcn.2014.09.003
  contributor:
    fullname: TG Heintz
– volume: 372
  start-page: 454
  issue: 3
  year: 2008
  ident: ppat.1009983.ref018
  article-title: Structural requirements of chromokinesin Kif4A for its proper function in mitosis
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2008.05.065
  contributor:
    fullname: G Wu
– volume: 30
  start-page: 68
  year: 2018
  ident: ppat.1009983.ref045
  article-title: Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections.
  publication-title: Curr Opin Virol
  doi: 10.1016/j.coviro.2018.04.004
  contributor:
    fullname: T Tu
– volume: 95
  start-page: e0076721
  issue: 15
  year: 2021
  ident: ppat.1009983.ref016
  article-title: MafF Is an Antiviral Host Factor That Suppresses Transcription from Hepatitis B Virus Core Promoter
  publication-title: J Virol
  doi: 10.1128/JVI.00767-21
  contributor:
    fullname: MK Ibrahim
– volume: 10
  start-page: 682
  issue: 10
  year: 2009
  ident: ppat.1009983.ref024
  article-title: Kinesin superfamily motor proteins and intracellular transport
  publication-title: Nature Reviews Molecular Cell Biology
  doi: 10.1038/nrm2774
  contributor:
    fullname: N Hirokawa
– volume: 129
  start-page: 709
  issue: 3
  year: 1995
  ident: ppat.1009983.ref009
  article-title: The Drosophila kinesin-like protein KLP3A is a midbody component required for central spindle assembly and initiation of cytokinesis
  publication-title: J Cell Biol
  doi: 10.1083/jcb.129.3.709
  contributor:
    fullname: BC Williams
– volume: 883
  start-page: 173346
  year: 2020
  ident: ppat.1009983.ref043
  article-title: Novel bexarotene derivatives: Synthesis and cytotoxicity evaluation for glioma cells in 2D and 3D in vitro models
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2020.173346
  contributor:
    fullname: NM Gretskaya
– volume: 20
  start-page: 835
  issue: 8
  year: 2015
  ident: ppat.1009983.ref038
  article-title: The FDA-approved drug irbesartan inhibits HBV-infection in HepG2 cells stably expressing sodium taurocholate co-transporting polypeptide.
  publication-title: Antivir Ther.
  doi: 10.3851/IMP2965
  contributor:
    fullname: C Ko
– volume: 288
  start-page: 31715
  issue: 44
  year: 2013
  ident: ppat.1009983.ref064
  article-title: Interleukin-1 and tumor necrosis factor-alpha trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID).
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M113.501122
  contributor:
    fullname: K Watashi
– volume: 81
  start-page: 117
  issue: 1
  year: 1995
  ident: ppat.1009983.ref010
  article-title: Xklp1, a chromosomal Xenopus kinesin-like protein essential for spindle organization and chromosome positioning
  publication-title: Cell
  doi: 10.1016/0092-8674(95)90376-3
  contributor:
    fullname: I Vernos
– volume: 14
  start-page: e0215234
  issue: 4
  year: 2019
  ident: ppat.1009983.ref021
  article-title: Retinoids induce antagonism between FOXO3A and FOXM1 transcription factors in human oral squamous cell carcinoma (OSCC) cells.
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0215234
  contributor:
    fullname: K Osei-Sarfo
– volume: 9
  start-page: 3257
  year: 2018
  ident: ppat.1009983.ref055
  article-title: Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into Hepatocytes.
  publication-title: Front Microbiol.
  doi: 10.3389/fmicb.2018.03257
  contributor:
    fullname: K Fukano
– volume: 120
  start-page: 140
  year: 2015
  ident: ppat.1009983.ref040
  article-title: Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na(+)-dependent taurocholate cotransporting polypeptide activity.
  publication-title: Antiviral Res
  doi: 10.1016/j.antiviral.2015.06.007
  contributor:
    fullname: XJ Wang
– volume: 14
  start-page: e1007055
  issue: 5
  year: 2018
  ident: ppat.1009983.ref013
  article-title: Role of kinesins in directed adenovirus transport and cytoplasmic exploration.
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1007055
  contributor:
    fullname: J Zhou
– volume: 149
  start-page: 141
  issue: 1
  year: 2000
  ident: ppat.1009983.ref020
  article-title: Evidence for the involvement of KIF4 in the anterograde transport of L1-containing vesicles
  publication-title: J Cell Biol
  doi: 10.1083/jcb.149.1.141
  contributor:
    fullname: D Peretti
– volume: 123
  start-page: 3420
  issue: Pt 20
  year: 2010
  ident: ppat.1009983.ref007
  article-title: Kinesins at a glance
  publication-title: J Cell Sci
  doi: 10.1242/jcs.064113
  contributor:
    fullname: SA Endow
– volume: 14
  start-page: 535
  issue: 5
  year: 2013
  ident: ppat.1009983.ref012
  article-title: HIV-1 induces the formation of stable microtubules to enhance early infection
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2013.10.012
  contributor:
    fullname: Y Sabo
– volume: 62
  start-page: 207
  issue: 1
  year: 2015
  ident: ppat.1009983.ref035
  article-title: Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+) -taurocholate cotransporting polypeptide knockout mice.
  publication-title: Hepatology
  doi: 10.1002/hep.27694
  contributor:
    fullname: D Slijepcevic
– volume: 7
  start-page: 126
  issue: 2
  year: 2005
  ident: ppat.1009983.ref056
  article-title: FoxM1 is required for execution of the mitotic programme and chromosome stability
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb1217
  contributor:
    fullname: J Laoukili
– volume: 78
  start-page: 3906
  issue: 6
  year: 1981
  ident: ppat.1009983.ref049
  article-title: State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.78.6.3906
  contributor:
    fullname: C Brechot
– volume: 111
  start-page: 100
  year: 2014
  ident: ppat.1009983.ref042
  article-title: (-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes.
  publication-title: Antiviral Res
  doi: 10.1016/j.antiviral.2014.09.009
  contributor:
    fullname: HC Huang
– volume: 678
  start-page: 90
  year: 2018
  ident: ppat.1009983.ref011
  article-title: The multiple functions of kinesin-4 family motor protein KIF4 and its clinical potential
  publication-title: Gene
  doi: 10.1016/j.gene.2018.08.005
  contributor:
    fullname: L Sheng
– volume: 38
  start-page: 188
  issue: 1
  year: 2019
  ident: ppat.1009983.ref014
  article-title: FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-019-1202-3
  contributor:
    fullname: G Hu
– volume: 68
  start-page: 4063
  issue: 6
  year: 1994
  ident: ppat.1009983.ref058
  article-title: The middle hepatitis B virus envelope protein is not necessary for infectivity of hepatitis delta virus
  publication-title: J Virol
  doi: 10.1128/jvi.68.6.4063-4066.1994
  contributor:
    fullname: C Sureau
– volume: 12
  start-page: 3503
  issue: 3
  year: 2015
  ident: ppat.1009983.ref015
  article-title: Hepatitis B virus upregulates the expression of kinesin family member 4A
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2015.3792
  contributor:
    fullname: CL Zhu
– volume: 63
  start-page: 1945
  issue: 5
  year: 1989
  ident: ppat.1009983.ref057
  article-title: Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen
  publication-title: J Virol
  doi: 10.1128/jvi.63.5.1945-1950.1989
  contributor:
    fullname: MY Kuo
– volume: 9
  start-page: 3225
  issue: 18
  year: 2018
  ident: ppat.1009983.ref048
  article-title: Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma.
  publication-title: J Cancer
  doi: 10.7150/jca.26052
  contributor:
    fullname: L Yang
– volume: 67
  start-page: 542
  issue: 3
  year: 2018
  ident: ppat.1009983.ref019
  article-title: Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo
  publication-title: Gut
  doi: 10.1136/gutjnl-2016-312162
  contributor:
    fullname: L Allweiss
– volume: 12
  start-page: 712241
  year: 2021
  ident: ppat.1009983.ref029
  article-title: The MS Remyelinating Drug Bexarotene (an RXR Agonist) Promotes Induction of Human Tregs and Suppresses Th17 Differentiation In Vitro.
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.712241
  contributor:
    fullname: CM Gaunt
– volume: 61
  start-page: 260
  issue: 1
  year: 2015
  ident: ppat.1009983.ref034
  article-title: Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype.
  publication-title: Hepatology
  doi: 10.1002/hep.27240
  contributor:
    fullname: FM Vaz
– volume: 81
  start-page: 4343
  issue: 8
  year: 2007
  ident: ppat.1009983.ref059
  article-title: Two potentially important elements of the hepatitis B virus large envelope protein are dispensable for the infectivity of hepatitis delta virus
  publication-title: J Virol
  doi: 10.1128/JVI.02478-06
  contributor:
    fullname: S Gudima
– volume: 10
  start-page: 74
  year: 2020
  ident: ppat.1009983.ref030
  article-title: E-cadherin Plays a Role in Hepatitis B Virus Entry Through Affecting Glycosylated Sodium-Taurocholate Cotransporting Polypeptide Distribution.
  publication-title: Front Cell Infect Microbiol
  doi: 10.3389/fcimb.2020.00074
  contributor:
    fullname: Q Hu
– volume: 290
  start-page: 5673
  issue: 9
  year: 2015
  ident: ppat.1009983.ref041
  article-title: Dysregulation of retinoic acid receptor diminishes hepatocyte permissiveness to hepatitis B virus infection through modulation of sodium taurocholate cotransporting polypeptide (NTCP) expression.
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M114.602540
  contributor:
    fullname: S Tsukuda
– volume: 166
  start-page: 991
  issue: 7
  year: 2004
  ident: ppat.1009983.ref008
  article-title: Loss of KLP-19 polar ejection force causes misorientation and missegregation of holocentric chromosomes
  publication-title: J Cell Biol
  doi: 10.1083/jcb.200403036
  contributor:
    fullname: J Powers
– volume: 280
  start-page: G1305
  issue: 6
  year: 2001
  ident: ppat.1009983.ref033
  article-title: Cell-specific basolateral membrane sorting of the human liver Na(+)-dependent bile acid cotransporter.
  publication-title: Am J Physiol Gastrointest Liver Physiol
  doi: 10.1152/ajpgi.2001.280.6.G1305
  contributor:
    fullname: AQ Sun
– volume: 55
  start-page: 373
  issue: 2
  year: 2012
  ident: ppat.1009983.ref032
  article-title: Hepatocyte polarization is essential for the productive entry of the hepatitis B virus
  publication-title: Hepatology
  doi: 10.1002/hep.24707
  contributor:
    fullname: A Schulze
SSID ssj0041316
Score 2.4637344
Snippet Intracellular transport via microtubule-based dynein and kinesin family motors plays a key role in viral reproduction and transmission. We show here that...
SourceID plos
doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage e1009983
SubjectTerms Adenosine triphosphatase
Agonists
Biology and life sciences
Care and treatment
Cell division
Cell surface
Depletion
Development and progression
Dynein
Family
Filaments
Fractionation
Gene expression
Genes
Genetic aspects
Genomes
Health aspects
Hep G2 Cells
Hepatitis B
Hepatitis B virus - physiology
Hepatitis Delta Virus - physiology
Humans
Immunofluorescence
Immunoprecipitation
Infections
Intracellular
Kinesin
Kinesins - genetics
Life cycles
Liver cancer
Localization
Medicine and Health Sciences
Methods
Molecular targeted therapy
Organic Anion Transporters, Sodium-Dependent - genetics
Organic Anion Transporters, Sodium-Dependent - metabolism
Patient outcomes
Proteins
Receptors
Research and Analysis Methods
Retinoid X receptors
Retinoid X Receptors - agonists
siRNA
Symporters - genetics
Symporters - metabolism
Transfection
Virus Internalization
Viruses
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9tAEF5aQ6GX0nfcpGVbCj2plncl7e4xL-NQMMVJQ25iX0pMi2QsK5B_0J_dmZUsqpLSS08C71hiZ0Y736CZbwj5yDwEYebjKLFcY4IiI5loFzGjvDQmFsqGIbbnYnElT06RJqcf9YU1YS09cKu4iZ9mBWdOFDZJwb-U0qnJphCmM5tOM-PD6RvLXTLVnsFwMoehpzgUJxI8y7qmOS6mk85Gn9drjfTRgJAkHwSlwN3fn9Cj9Y-qvg9-_llF-VtYmj0lTzo8SQ_bfTwjD3z5nDxqJ0zevSA_wQ3odyxtX5X0y9ksoaFVBPAlnR9dTuYnlzSMFqHdvB64erpp59ODxWhV0LrZFNp6urg4_kpD6OtaN6kuHQXLUONpW1DuHTV3dHm1pPq6QkremsJjb1fbTfWSfJudXhzPo274QmQhZG8jJo0CfRmAXwCBUkheMyc590go6QtMO5TXqYgdc7FNvBDCARYyxVTJxGrAMa_IqKxKv0co4kinmLQasETinMQ0kxu4iVVammRMop3283XLsZGHD20CcpNWjTlaK--sNSZHaKJeFhmyww_gN3nnN_m__GZMPqCBc-TAKLHI5lo3dZ2fnS_yw0wpwGlxwv8qtBwIfeqEigocwequsQE2j9xaA8mDgSS8yXawvIfOtttznbMsRcDOEwb_3Dng_cvv-2W8KRbOlb5qUAbZiTLBQOZ166-93jicv4BexZiIgScPFDtcKVc3gYJcKoFEQW_-hyX2yWOGPSWhsO-AjLabxr8lD2vXvAsv9S_l8Uv7
  priority: 102
  providerName: Directory of Open Access Journals
Title The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro
URI https://www.ncbi.nlm.nih.gov/pubmed/35312737
https://www.proquest.com/docview/2651150342
https://search.proquest.com/docview/2641856722
https://pubmed.ncbi.nlm.nih.gov/PMC8970526
https://doaj.org/article/e16f32d7fc4542599a5b616006c516be
http://dx.doi.org/10.1371/journal.ppat.1009983
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF5qQ6GX0nfcpmFbCj3Jj9Vjd4-JE-NQaoKThtzEvuSaJpKw7EL-QX92Z1aSqUp66cngHcnWzOzON_bMN4R8Yg6CMHPjIDKhwgRFBCJSNmBaOqH1mEvjh9he8sWNOD1Dmpy47YXxRftGr4f57d0wX3_3tZXlnRm1dWKji69TITnSlIx6pAfYsE3R6-MXDmU_7xTn4QQ8TJKmXy7kk1FjnmFZKmSOBnAkcI5OCH4IUZx3QpNn8N-f0_3ytqgeAqF_11L-EZxmz8jTBlXS4_rbPyePXP6CPK7nTN6_JL_AGegPLHBf5_TL-SyivmEEUCadn1yP5qfX1A8Yoc3UHnh1dFNPqQe70SKj1W6TKePo4mp6QX0AbBo4qcotBftQ7WhdVu4s1fd0ebOkalUgMW9F4WN_rreb4hX5Nju7ms6DZgRDYCBwbwMmtATVaQBhAIRiSGETK8LQIa2kyzD5kE7FfGyZHZvIcc4tICKdTaSIjAI085r08yJ3B4QimrSSCaMAUUTWCkw2Qw03MVIJHQ1I0Go_LWumjdT_3cYhQ6nVmKLh0sZwA3KCJtrLIk-2f6PYrNLGW1I3SbKQWZ6ZKIbTSUoV62QCIC8x8STRbkA-ooFTZMLIsdRmpXZVlZ5fLtLjREpAa-Mo_KfQsiP0uRHKCnAEo5r2Bnh4ZNjqSB52JGE_m87yATpb-8xVypIYYXsYMbiydcCHlz_sl_GmWD6Xu2KHMshRlHAGMm9qf93rrfX-AeEdT-4otrsC-9ITkTf78O1_X_mOPGHYTuJr-g5Jf7vZufekV9ndkf9x5Mhv7d_i8E4b
link.rule.ids 230,315,729,782,786,866,887,2108,27935,27936,53803,53805
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF7RIAQX3tBAgQUhcXLi-LW7xzZtlKhtVKWl6s3al0NEa0dxgtR_wM9mZm1HGJVLT5GyY0e7MzvzjTLzDSFfAwtBOLC-F-lQYoLCPR5J4wVKWK6Uz4R2Q2zP2fSKHx4hTU7c9MK4on2tFr38-qaXL3642srlje43dWL9s9MhFwxpSvo75CHcVz9skvTKAYNbdhNPcSKOx8IkqTvmQjbo1wrqLZcSuaMBHnGcpBOCJUIcZ63g5Dj8t566s7wuyrtg6L_VlH-Fp9Gze27sOXla41G6Xy2_IA9s_pI8qiZU3r4iv8GM6E8sjV_k9HgyiqhrNQF8SscHl_3x4SV1o0loPe8HPi1dVfPtQeO0yGi5WWVSWzq9GJ5RFzrr1k8qc0NBs1RZWhWkW0PVLZ1dzaicF0jpW1L42V-L9ap4Tb6Pji6GY68e3uBpCPlrL-BKwJErgG8AoWJIfhPDw9AiIaXNMG0RVsbMN4HxdWQZYwawlMoGgkdaAg56Qzp5kdtdQhGHGhFwLQGLRMZwTFNDBS_RQnIVdYnXaC1dVhwdqfujjkFuUx1jigpPa4V3yQGqdiuLDNvui2I1T2t1pHaQZGFgWKajGPyaEDJWyQDgYaLjQaJsl3xBw0iRQyPHIp253JRlOjmfpvuJEIDz_Cj8r9CsJfStFsoKMCAt68YI2Dxyc7Uk91qS4Al0a3kXjbTZc5kGSYyAP4wCeLIx3LuXP2-X8aVYeJfbYoMyyG6UsABk3lZ2vj235tZ0CWvdgNbBtlfA8B2FeW3o7-795CfyeHxxepKeTKbH78mTAJtSXGXgHumsVxv7geyUZvPROYY_6DVitg
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEF7RIBAX3tBAgQUhcXLs-LXrY5s0alSIorRUvVn7cohobStOkPoP-NnMrO0Io3KBU6Ts2NHuzM58o8x8Q8hH30AQ9o3nhCoQmKBwh4dCO75MDJfSY4myQ2zP2OySj4-RJmc36ssW7Su5GuRX14N89c3WVpbXym3rxNz5lxFPGNKUuKXO3D1yF-6sF7WJeu2EwTXbqac4FcdhQRw3XXMBG7qNkgZlKZA_GiASx2k6AVgjxHLWCVCWx3_nrXvlVVHdBkX_rKj8LURNHv3H5h6Thw0upYe1yBNyx-RPyb16UuXNM_ITzIl-xxL5VU5Pp5OQ2pYTwKn05OjCPRlfUDuihDZzf-DT0HU95x40T4uMVtt1JpShs_PRnNoQ2rSAUpFrChqm0tC6MN1oKm_o4nJBxbJAat-Kws_-WG3WxXPydXJ8PjpxmiEOjoLQv3F8LhM4dgkwDqBUBElwrHkQGCSmNBmmL4kREfO0rz0VGsaYBkwls2HCQyUAD70gvbzIzT6hiEd14nMlAJOEWnNMVwMJL1GJ4DLsE6fVXFrWXB2p_cOOQY5TH2OKSk8bpffJEap3J4tM2_aLYr1MG5WkZhhnga9ZpsII_FuSiEjGQ4CJsYqGsTR98gGNI0UujRyLdZZiW1Xp9GyWHsZJAnjPC4O_Ci06Qp8aoawAI1KiaZCAzSNHV0fyoCMJHkF1lvfRUNs9V6kfRwj8g9CHJ1vjvX35_W4ZX4oFeLkptiiDLEcx80HmZW3ru3Nrb06fsM4t6BxsdwWM31KZN8b-6p-ffEfuz8eT9PN0dvqaPPCxN8UWCB6Q3ma9NW_IXqW3b61v-AUKpGU2
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+kinesin+KIF4+mediates+HBV%2FHDV+entry+through+the+regulation+of+surface+NTCP+localization+and+can+be+targeted+by+RXR+agonists+in+vitro&rft.jtitle=PLoS+pathogens&rft.au=Gad%2C+Sameh+A&rft.au=Sugiyama%2C+Masaya&rft.au=Tsuge%2C+Masataka&rft.au=Wakae%2C+Kosho&rft.date=2022-03-01&rft.eissn=1553-7374&rft.volume=18&rft.issue=3&rft.spage=e1009983&rft.epage=e1009983&rft_id=info:doi/10.1371%2Fjournal.ppat.1009983&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1553-7374&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1553-7374&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1553-7374&client=summon